In this study, we found that, upon Y27632 treatment, the phosphorylation levels of MYPT1 (Thr 853) were reduced in all HCC cell lines tested (Figure 5A), while the total MYPT1 levels remained unchanged. The gene discussed is PPP1R12A; the disease is hepatocellular carcinoma.